Taro Recalls Subpotent Ciclopirox Shampoo 1% Prescription Bottles
Taro Pharmaceuticals is recalling 850 bottles of Ciclopirox Shampoo 1% because the product is subpotent. The recall is voluntary and nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Taro Pharmaceuticals U.S.A., Inc. is voluntarily recalling 850 bottles of Ciclopirox Shampoo 1%, Net Wt. 120 mL. The product is a prescription-only topical medication manufactured by Taro Pharmaceuticals Inc. in Brampton, Ontario, Canada, and distributed by Taro Pharmaceuticals U.S.A., Inc. in Hawthorne, New York. The specific lot affected is H3135, with an expiration date of January 2015. The NDC for the product is 51672-1351-8.
The recall was initiated because the drug was found to be subpotent, meaning it did not contain the full amount of the active ingredient required by the label. The FDA classified this recall as Class III, which indicates that use of or exposure to the violative product is not likely to cause adverse health consequences. The recall was initiated on October 16, 2013, and was terminated on May 18, 2018.
The affected product was distributed nationwide. Consumers and healthcare providers who have this specific lot of Ciclopirox Shampoo should stop using it and contact their healthcare provider or pharmacist for guidance. The recall was initiated by the firm and involved notification via email, fax, letter, press release, telephone, or visit.
The recalled product
- Product
- CICLOPIROX (CICLOPIROX)
- Brand
- CICLOPIROX
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Category
- Drug — Topical Antifungal
- Hazard
- Affected units
- 850
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: H3135
- Exp. January 2015
UPCs (1)
- 0351672135188
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CICLOPIROX
- LowPerrigo Recalls Ciclopirox Shampoo Due to Stability Testing Failures
FDA (Drugs) · 2019-02-27
Same manufacturer · Taro Pharmaceuticals U.S.A., Inc.
See all →- ModerateHydrocortisone & Acetic Acid Otic Solution Recalled for Potency and Impurity Failures
FDA (Drugs) · 2024-08-21
- ModerateClotrimazole and Betamethasone Topical Cream Recalled for Failed Potency Specifications
FDA (Drugs) · 2022-04-06
- SevereClobetasol Propionate Ointment Recalled for Microbial Contamination
FDA (Drugs) · 2022-01-19
- HighTaro Recalls Nortriptyline Hydrochloride Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2021-02-10
- ModerateTaro Recalls Rite Aid Clotrimazole Cream Due to Impurity
FDA (Drugs) · 2020-12-23
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02